Regulatory capture occurs when government agencies prioritize industry interests over public welfare. Learn how revolving doors, lobbying, and information asymmetry weaken regulation - and what you can do about it.
Author: Scott McRobbie - Page 3
Prescription labels cause dangerous errors when misunderstood. Learn common mistakes and how to avoid them. Discover patient and pharmacy strategies for safer medication use. Stay informed to protect your health.
Pharmacist-led substitution programs reduce medication errors, lower hospital readmissions, and save costs. Learn how they work, proven outcomes, and implementation steps based on real-world data and expert insights.
Health and Medicine
How Lower Generic Drug Prices Improve Patient Adherence and Cut Healthcare Costs
Lower generic drug prices significantly improve patient adherence, reduce hospitalizations, and save billions in healthcare costs. Studies show patients are far more likely to take their meds when generics cost 80% less than brand names.
Generics are the hidden force keeping global healthcare spending from spiraling out of control. From the U.S. to Nigeria, these low-cost drugs save billions and make treatment possible for millions.
Dextromethorphan in common cough syrups can cause life-threatening serotonin syndrome when mixed with MAOI antidepressants. Learn the risks, symptoms, and safe alternatives.
Cancer medication combinations are complex, and switching to generic versions isn't as simple as it seems. Bioequivalence standards designed for single drugs often fail to ensure safety and effectiveness in multi-drug regimens, creating real risks for patients.
Health and Medicine
Medications That Change Your Sense of Smell: What You Need to Know About Dysosmia
Many medications can distort your sense of smell, causing food to taste like metal or smoke to appear out of nowhere. This condition, called dysosmia, is more common than you think-and often missed by doctors. Learn which drugs cause it, how long it lasts, and what to do next.
The global generic drug market is set to grow rapidly through 2030, driven by patent expirations, aging populations, and cost pressures. Biosimilars, India and China's manufacturing power, and regulatory shifts are reshaping access to affordable medicines worldwide.
Generic drug shortages are worsening in the U.S., with 270 active shortages as of early 2026. These aren't random glitches-they're caused by low profit margins, overseas manufacturing, and a broken pricing system that puts patient access at risk.